During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Here's a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga's Analyst Stock Ratings.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the utilities sector.
Ameren Corporation AEE
- Dividend Yield: 3.18%
- Barclays analyst Eric Beaumont initiated coverage on the stock with an Equal-Weight rating and a price target of $80 on Aug. 23, 2023. This analyst has an accuracy rate of 70%.
- Mizuho analyst Anthony Crowdell maintained a Neutral rating and slashed the price target from $87 to $82 on Aug. 11, 2023. This analyst has an accuracy rate of 65%.
- Recent News: Ameren posted better-than-expected quarterly results.
PNM Resources, Inc. PNM
- Dividend Yield: 3.32%
- Citigroup analyst Ryan Levine maintained a Neutral rating and raised the price target from $50.3 to $51 on June 22, 2023. This analyst has an accuracy rate of 68%.
- Mizuho analyst Anthony Crowdell downgraded the stock from Buy to Neutral and cut the price target from $51 to $50.3 on Jan. 9, 2023. This analyst has an accuracy rate of 65%.
- Recent News: PNM Resources reported better-than-expected second-quarter earnings.
ONE Gas, Inc. OGS
- Dividend Yield: 3.59%
- Stifel analyst Selman Akyol maintained a Hold rating and increased the price target from $81 to $82 on Aug. 15, 2023. This analyst has an accuracy rate of 66%.
- Guggenheim analyst Shahriar Pourreza maintained a Neutral rating and cut the price target from $77 to $73 on July 7, 2023. This analyst has an accuracy rate of 64%.
- Recent News: ONE Gas posted weaker-than-expected results for the latest quarter.
Read More: BioRestorative Therapies And 3 Other Stocks Under $3 Insiders Are Buying
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.